Science Explorer Interactive view Map
Company · Cambridge · United Kingdom

Clovis Oncology (United Kingdom)

clovisoncology.comROR OpenAlex
Research works
46
▼ 50% vs 2013–17
Citations
2.2k
47.0 per fractional work
Top-10% rate
9.0%
record average 16.5%
Open access
57%
world 28%

Not ranked overall: Clovis Oncology (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.03× its world share, 1 worksBiochemistry, Geneti…Chemistry: 0.89× its world share, 0 worksChemistryEngineering: 0.97× its world share, 0 worksEngineeringHealth Professions: 0.24× its world share, 0 worksHealth ProfessionsMedicine: 3.15× its world share, 2 worksMedicineNursing: 2.28× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.14× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.0×. Every wedge is a field page.

Which keywords describe research at Clovis Oncology (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Climate Change, Remote Sensing, Hydrological Modeling, Water Resources, Chemotherapy, Mass Spectrometry, Sediment Transport and Land Use Change.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Climate Change6▲ 4.6×13 topics
  2. Remote Sensing4▲ 6.9×6 topics
  3. Hydrological Modeling3▲ 32×2 topics
  4. Chemotherapy2▲ 7.2×14 topics
  5. Water Resources2▲ 23×3 topics
  6. Mass Spectrometry2▲ 22×3 topics
  7. Biomarkers2▲ 7.2×5 topics
  8. Cancer2▲ 3.2×14 topics
  9. Cancer Therapy2▲ 6.7×6 topics
  10. Global Hydrology2▲ 71×1 topic
  11. Land Use Change2▲ 15×2 topics
  12. Model Evaluation2▲ 39×1 topic
  13. Sediment Transport2▲ 26×2 topics
  14. Drought2▲ 45×2 topics
  15. Evapotranspiration2▲ 52×2 topics
  16. Glycosylation2▲ 18×3 topics
  17. Proteomics2▲ 32×2 topics
  18. Clinical Trials2▲ 5.8×7 topics
  19. Immunotherapy2▲ 5.5×10 topics
  20. Lignocellulosic Biomass2▲ 34×2 topics
  21. Global Warming2▲ 9.2×2 topics
  22. Hydrological2▲ 132×1 topic
  23. Monitoring2▲ 26×1 topic
  24. Metastasis1▲ 9.1×8 topics
  25. Protein Identification1▲ 127×1 topic
  26. Quantitative Analysis1▲ 18×1 topic
  27. Homologous Recombination1▲ 41×2 topics
  28. Immune System1▲ 8.6×2 topics
  29. BRCA Mutation1▲ 150×1 topic
  30. Biomass1▲ 30×2 topics
  31. Cell Death1▲ 13×2 topics
  32. Data Analysis1▲ 7.9×4 topics
  33. PARP Inhibitors1▲ 150×1 topic
  34. Synthetic Lethality1▲ 105×2 topics
  35. Wastewater Treatment1▲ 14×2 topics
  36. Bio-oil1▲ 68×1 topic
  37. Genomic Analysis1▲ 8.4×3 topics
  38. Ovarian Cancer1▲ 27×2 topics
  39. Pyrolysis1▲ 40×1 topic
  40. Risk Perception1▲ 12×2 topics

Which research topics does Clovis Oncology (United Kingdom) publish most on?

By volume in 2022–2025: Vehicle emissions and performance, Advanced Measurement and Detection Methods, Fibroblast Growth Factor Research and Cardiac Valve Diseases and Treatments.

Vehicle emissions and performance: 0 fractional worksAdvanced Measurement and Detection Methods: 0 fractional worksFibroblast Growth Factor…0Fibroblast Growth Factor Research: 0 fractional worksCardiac Valve Diseases and Treatments: 0 fractional worksInfective Endocarditis Diagnosis and Management: 0 fractional worksAngiogenesis and VEGF in Cancer: 0 fractional worksRenal cell carcinoma treatment: 0 fractional worksProstate Cancer Treatmen…0Prostate Cancer Treatment and Research: 0 fractional worksPARP inhibition in cancer therapy: 0 fractional worksCardiac Structural Anomalies and Repair: 0 fractional works
Automotive EngineeringElectrical and Electronic EngineeringMolecular BiologyCardiology and Cardiovascular Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Vehicle emissions and performance Automotive Engineering 0 works
  2. 2 Advanced Measurement and Detection Methods Electrical and Electronic Engineering 0 works
  3. 3 Fibroblast Growth Factor Research Molecular Biology 0 works
  4. 4 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 0 works
  5. 5 Infective Endocarditis Diagnosis and Management Epidemiology 0 works
  6. 6 Angiogenesis and VEGF in Cancer Molecular Biology 0 works
  7. 7 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
  8. 8 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  9. 9 PARP inhibition in cancer therapy Oncology 0 works
  10. 10 Cardiac Structural Anomalies and Repair Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.1%not open42.9%

World: 28% of research is openly available.

with international co-authors58.6%domestic only41.4%

World: 19% is written across borders.

How has Clovis Oncology (United Kingdom)'s research output changed?

Output in 2018–2022 was 50% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.